Answers are grounded in this paper and cite their sources.
Fibrinolytic enzymes, particularly streptokinase, are now widely used to treat empyema thoracis. Recent in vitro evidence suggests that streptokinase has no effect on pus viscosity but that deoxyribonuclease (DNase) reduces the viscosity of pus. We report the first use of human recombinant DNase given intrapleurally to treat an empyema which had not resolved after standard treatment with streptokinase.
No takes yet. Share an insight, caveat, or question.
Graham Simpson (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: